ZA200907355B - Titration of tapentadol - Google Patents

Titration of tapentadol

Info

Publication number
ZA200907355B
ZA200907355B ZA200907355A ZA200907355A ZA200907355B ZA 200907355 B ZA200907355 B ZA 200907355B ZA 200907355 A ZA200907355 A ZA 200907355A ZA 200907355 A ZA200907355 A ZA 200907355A ZA 200907355 B ZA200907355 B ZA 200907355B
Authority
ZA
South Africa
Prior art keywords
tapentadol
titration
administration
unitbcontaining
unitacontaining
Prior art date
Application number
ZA200907355A
Other languages
English (en)
Inventor
Claudia Lange
Ferdinand Rombout
Original Assignee
Gruenenthal Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38123877&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ZA200907355(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Gruenenthal Gmbh filed Critical Gruenenthal Gmbh
Publication of ZA200907355B publication Critical patent/ZA200907355B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Adhesive Tapes (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA200907355A 2007-04-23 2009-10-20 Titration of tapentadol ZA200907355B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP07008218A EP1985292A1 (de) 2007-04-23 2007-04-23 Titration von Tapentadol

Publications (1)

Publication Number Publication Date
ZA200907355B true ZA200907355B (en) 2010-08-25

Family

ID=38123877

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200907355A ZA200907355B (en) 2007-04-23 2009-10-20 Titration of tapentadol

Country Status (22)

Country Link
US (4) US20090012180A1 (de)
EP (5) EP1985292A1 (de)
JP (4) JP5933176B2 (de)
KR (3) KR20100017267A (de)
CN (1) CN101730530B (de)
AT (1) ATE534378T1 (de)
AU (1) AU2008241013B2 (de)
CA (1) CA2683786C (de)
CY (1) CY1112320T1 (de)
DK (1) DK2148670T3 (de)
ES (1) ES2378255T3 (de)
HK (1) HK1140940A1 (de)
HR (1) HRP20120147T1 (de)
IL (1) IL201479A (de)
MX (1) MX2009011444A (de)
NZ (1) NZ580415A (de)
PL (1) PL2148670T3 (de)
PT (1) PT2148670E (de)
RU (1) RU2472497C2 (de)
SI (1) SI2148670T1 (de)
WO (1) WO2008128740A1 (de)
ZA (1) ZA200907355B (de)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1985292A1 (de) * 2007-04-23 2008-10-29 Grünenthal GmbH Titration von Tapentadol
HUE047438T2 (hu) * 2008-10-30 2020-04-28 Gruenenthal Gmbh Új és potens tapentadol dózisformák
US8870876B2 (en) * 2009-02-13 2014-10-28 Tarsus Medical Inc. Methods and devices for treating hallux valgus
US8277459B2 (en) 2009-09-25 2012-10-02 Tarsus Medical Inc. Methods and devices for treating a structural bone and joint deformity
US8652141B2 (en) 2010-01-21 2014-02-18 Tarsus Medical Inc. Methods and devices for treating hallux valgus
US20130116333A1 (en) * 2010-05-05 2013-05-09 Ratiopharm Gmbh Solid tapentadol in non-crystalline form
US8696719B2 (en) 2010-06-03 2014-04-15 Tarsus Medical Inc. Methods and devices for treating hallux valgus
JP5856613B2 (ja) * 2010-06-30 2016-02-10 グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング 過敏性腸症候群の治療において使用するためのタペンタドール
KR102146233B1 (ko) * 2010-07-23 2020-08-21 그뤼넨탈 게엠베하 ３-(３-디메틸아미노-１-에틸-２-메틸-프로필)-페놀의 염 또는 공결정
CN101948397A (zh) * 2010-09-07 2011-01-19 天津泰普药品科技发展有限公司 镇痛药他喷他多重要中间体的制备方法
HUE027514T2 (en) * 2011-03-04 2016-10-28 Gruenenthal Gmbh Parenteral administration of tapentadol
PT2680832T (pt) 2011-03-04 2019-10-28 Gruenenthal Gmbh Formulação farmacêutica aquosa de tapentadol para administração oral
RS56692B1 (sr) 2011-03-04 2018-03-30 Gruenenthal Gmbh Polučvrsta vodena farmaceutska kompozicija koja sadrži tapentadol
US20120309840A1 (en) * 2011-04-05 2012-12-06 Gruenenthal Gmbh Treatment of Pain Associated with Trigeminal Neuralgia
PT2694049T (pt) 2011-04-05 2019-02-06 Gruenenthal Gmbh Tapentadol para prevenir a cronicidade da dor
RS60152B1 (sr) 2011-04-29 2020-05-29 Gruenenthal Gmbh Tapentadol za sprečavanje i lečenje depresije i anksioznosti
PL2968182T3 (pl) * 2013-03-15 2018-10-31 SpecGx, LLC Zniechęcająca do nadużywania stała postać dawkowania dla natychmiastowego uwalniania z funkcjonalnym rowkiem
EP2845625A1 (de) * 2013-09-04 2015-03-11 Grünenthal GmbH Tepentadol zur Verwendung bei der Behandlung von Fibromyalgie und chronischem Ermüdungssyndrom
PT3479823T (pt) 2015-03-27 2020-09-29 Gruenenthal Gmbh Formulação estável para administração parentérica de tapentadol
ES2869981T3 (es) * 2015-05-26 2021-10-26 Technophage Investig E Desenvolvimento Em Biotecnologia Sa Composiciones para su uso en el tratamiento de la enfermedad de parkinson y trastornos relacionados
BR112018017167A2 (pt) * 2016-02-29 2019-01-02 Gruenenthal Gmbh titulação de cebranopadol
MX2019003257A (es) 2016-09-23 2019-06-10 Gruenenthal Gmbh Formulacion estable para la administracion parenteral de tapentadol.
MX2022011505A (es) 2020-03-16 2022-10-07 Gruenenthal Gmbh Comprimido ranurado.
BR112023018841A2 (pt) * 2021-03-17 2023-12-26 Actelion Pharmaceuticals Ltd Sistema de dosagem farmacêutica
EP4333820A1 (de) * 2021-05-07 2024-03-13 Grünenthal GmbH Tapentadol zur behandlung von neuropathischem schmerz bei covid-19-patienten

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4783337A (en) 1983-05-11 1988-11-08 Alza Corporation Osmotic system comprising plurality of members for dispensing drug
US4612008A (en) 1983-05-11 1986-09-16 Alza Corporation Osmotic device with dual thermodynamic activity
US4765989A (en) * 1983-05-11 1988-08-23 Alza Corporation Osmotic device for administering certain drugs
JPS6327805A (ja) 1986-07-21 1988-02-05 Sumitomo Electric Ind Ltd 光フアイバの接続用部材及びそれを用いた接続方法
DE4426245A1 (de) 1994-07-23 1996-02-22 Gruenenthal Gmbh 1-Phenyl-3-dimethylamino-propanverbindungen mit pharmakologischer Wirkung
US6339105B1 (en) * 1999-10-12 2002-01-15 Ortho-Mcneil Pharmaceutical, Inc. Analgesic regimen
PE20030527A1 (es) * 2001-10-24 2003-07-26 Gruenenthal Chemie Formulacion farmaceutica con liberacion retardada que contiene 3-(3-dimetilamino-1-etil-2-metil-propil) fenol o una sal farmaceuticamente aceptable del mismo y tabletas para administracion oral que la contienen
NZ539936A (en) * 2002-12-13 2007-06-29 Euro Celtique Sa Transdermal buprenorphine dosage regimen for analgesia
US7413749B2 (en) * 2003-03-11 2008-08-19 Purdue Pharma L.P. Titration dosing regimen for controlled release tramadol
EP1985292A1 (de) 2007-04-23 2008-10-29 Grünenthal GmbH Titration von Tapentadol
DE102007019417A1 (de) * 2007-04-23 2008-11-13 Grünenthal GmbH Tapentadol zur Schmerzbehandlung bei Arthrose

Also Published As

Publication number Publication date
PT2148670E (pt) 2012-01-24
JP2016128468A (ja) 2016-07-14
KR20150027840A (ko) 2015-03-12
JP2010531296A (ja) 2010-09-24
IL201479A0 (en) 2010-05-31
DK2148670T3 (da) 2012-03-12
ES2378255T3 (es) 2012-04-10
CA2683786C (en) 2021-10-26
US20190290603A1 (en) 2019-09-26
RU2009142940A (ru) 2011-05-27
AU2008241013B2 (en) 2013-06-20
EP3603630A1 (de) 2020-02-05
SI2148670T1 (sl) 2012-03-30
EP2148670A1 (de) 2010-02-03
IL201479A (en) 2016-04-21
HK1140940A1 (en) 2010-10-29
EP1985292A1 (de) 2008-10-29
NZ580415A (en) 2012-04-27
US20090012180A1 (en) 2009-01-08
WO2008128740A1 (en) 2008-10-30
HRP20120147T1 (hr) 2012-03-31
PL2148670T3 (pl) 2012-04-30
JP5933176B2 (ja) 2016-06-08
WO2008128740A8 (en) 2010-06-17
KR20180004839A (ko) 2018-01-12
US20160074342A1 (en) 2016-03-17
KR20100017267A (ko) 2010-02-16
KR102078999B1 (ko) 2020-02-19
JP2019131598A (ja) 2019-08-08
JP2018030864A (ja) 2018-03-01
MX2009011444A (es) 2009-11-05
CN101730530A (zh) 2010-06-09
CY1112320T1 (el) 2015-12-09
CA2683786A1 (en) 2008-10-30
EP3143993A1 (de) 2017-03-22
ATE534378T1 (de) 2011-12-15
EP2148670B1 (de) 2011-11-23
EP2422778A1 (de) 2012-02-29
US11344512B2 (en) 2022-05-31
RU2472497C2 (ru) 2013-01-20
US20170079938A1 (en) 2017-03-23
AU2008241013A1 (en) 2008-10-30
CN101730530B (zh) 2013-10-23

Similar Documents

Publication Publication Date Title
HK1140940A1 (en) Titration of tapentadol
HK1148202A1 (en) Pharmaceutical solutions, process of preparation and therapeutic uses
HK1129594A1 (en) Use of substituted 2-aminotetralines for the manufacture of a medicament for the prevention, alleviation and/or treatment of various types of pain
MY151048A (en) Use of flibanserin for the treatment of post-menopausal sexual desire disorders
MX2009002196A (es) Oblea de buprenorfina para terapia de sustitucion de farmacos.
MY153408A (en) Novel methods
WO2010014690A3 (en) Medical devices for therapeutic agent delivery
UA105210C2 (ru) Противораковая вакцина и ее применение
IN2012DN01435A (de)
CY1115455T1 (el) Χρησιμοποιηση ενωσεων 1-φαινυλο-3-διμεθυλαμινο-προπανιου για τη θεραπεια του πονου νευροπαθειας
TN2012000515A1 (en) Pharmaceutical compositions of co-crystals of tramadol and coxibs
MX2014004862A (es) Formulaciones de polimero acrilico.
WO2008087186A3 (en) Peptides for use in the treatment of obesity
WO2011026125A3 (en) Gastric retentive pharmaceutical compositions for immediate and extended release of acetaminophen
MX2010001449A (es) Bromhidrato de bupropion y aplicaciones terapeuticas.
WO2008087188A3 (en) Peptides for use in the treatment of obesity
EP2073819A4 (de) Topisches co-enzym-q10-formulierungen und behandlung von schmerzen, müdigkeit und wunden
MY150931A (en) Substituted oxazolidinones and their use
WO2012100043A3 (en) Controlled release oral pharmaceutical dosage forms comprising mgbg
MX2009011999A (es) Extruidos con enmascaramiento del sabor mejorado.
MX2009008108A (es) Composicion farmaceutica que contiene una combinacion de tramadol y ketoprofeno.
MX2009008813A (es) Composicion farmaceutica que contiene floroglucinol y paracetamol.
WO2007135123A3 (en) Mirtazapine for the treatment of neuropathic pain
EA201000738A1 (ru) Медицинское применение 3-(2,2,2-триметилгидразиниум)пропионат гидрофумарата и дигидрофосфата
UA99093C2 (ru) Применение фенофибрата или его производного для лечения диабетической ретинопатии